DVAX logo

DVAX
Dynavax Technologies Corp.

18,972
Mkt Cap
$1.3B
Volume
268,921.00
52W High
$14.63
52W Low
$9.20
PE Ratio
-28.93
DVAX Fundamentals
Price
$11.16
Prev Close
$11.05
Open
$11.16
50D MA
$10.21
Beta
0.67
Avg. Volume
1.26M
EPS (Annual)
$0.2048
P/B
2.43
Rev/Employee
$684,558.03
Loading...
Loading...
News
all
press releases
Dynavax to Participate at the 8th Annual Evercore Healthcare Conference
Dynavax to Participate at the 8th Annual Evercore Healthcare Conference Dynavax to Participate at the 8th Annual Evercore Healthcare Conference PR Newswire EMERYVILLE, Calif., Nov. 19, 2025...
PR Newswire·20h ago
News Placeholder
More News
News Placeholder
Los Angeles Capital Management LLC Acquires Shares of 32,350 Dynavax Technologies Corporation $DVAX
Los Angeles Capital Management LLC bought a new position in shares of Dynavax Technologies Corporation (NASDAQ:DVAX - Free Report) in the second quarter, according to the company in its most recent...
MarketBeat·2d ago
News Placeholder
William Blair Issues Pessimistic Forecast for DVAX Earnings
Dynavax Technologies Corporation (NASDAQ:DVAX - Free Report) - Stock analysts at William Blair decreased their FY2025 earnings per share (EPS) estimates for shares of Dynavax Technologies in a report...
MarketBeat·10d ago
News Placeholder
William Blair Issues Optimistic Forecast for DVAX Earnings
Dynavax Technologies Corporation (NASDAQ:DVAX - Free Report) - Analysts at William Blair boosted their Q1 2026 earnings per share (EPS) estimates for shares of Dynavax Technologies in a research note...
MarketBeat·12d ago
News Placeholder
Dynavax Technologies (NASDAQ:DVAX) Posts Quarterly Earnings Results, Beats Expectations By $0.07 EPS
Dynavax Technologies (NASDAQ:DVAX - Get Free Report) released its earnings results on Wednesday. The biopharmaceutical company reported $0.21 earnings per share (EPS) for the quarter, beating...
MarketBeat·14d ago
News Placeholder
Dynavax Technologies (DVAX) Surpasses Q3 Earnings Estimates
Dynavax Technologies (DVAX) delivered earnings and revenue surprises of +50.00% and -0.23%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·15d ago
News Placeholder
Qiagen (QGEN) Q3 Earnings and Revenues Surpass Estimates
Qiagen (QGEN) delivered earnings and revenue surprises of +5.17% and +1.25%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·16d ago
News Placeholder
Nuvation Bio Inc. (NUVB) Reports Q3 Loss, Tops Revenue Estimates
Nuvation Bio (NUVB) delivered earnings and revenue surprises of +5.88% and +95.53%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·17d ago
News Placeholder
Dynavax to Report Third Quarter 2025 Financial Results and Host Conference Call on November 5, 2025
Dynavax to Report Third Quarter 2025 Financial Results and Host Conference Call on November 5, 2025 Dynavax to Report Third Quarter 2025 Financial Results and Host Conference Call on November 5, 2025...
PR Newswire·29d ago
News Placeholder
Dynavax Presents Positive Topline Data from Part 1 of Phase 1/2 Trial for Shingles Vaccine Candidate at IDWeek 2025 and Announces Initiation of Part 2 of Trial
Dynavax Presents Positive Topline Data from Part 1 of Phase 1/2 Trial for Shingles Vaccine Candidate at IDWeek 2025 and Announces Initiation of Part 2 of Trial Dynavax Presents Positive Topline Data...
PR Newswire·30d ago

Latest DVAX News

View

Advertisement|Remove ads.

Advertisement|Remove ads.